Silexion Therapeutics Corp - SLXN
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$43K
QoQ value delta ($000)
+$10K
(+30.3%)
Implied price effect (QoQ)
-34.58%
Shares
Total shares
36,479
QoQ shares delta
+18,164
(+99.18%)
Total shares held by funds (by quarter)
Market chart (SLXN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CITADEL ADVISORS LLC | 26 | 20,926 | 0.0% |
| TWO SIGMA SECURITIES, LLC | 14 | 11,657 | 0.0% |
| MONTAG A & ASSOCIATES INC | 3 | 3,000 | 0.0% |
| JONES FINANCIAL COMPANIES LLLP | 0 | 26 | 0.0% |
| UBS Group AG | 0 | 517 | 0.0% |
| Pflug Koory, LLC | 0 | 333 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 20 | 0.0% |